Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Correlogic Systems; NanoString Technologies; Covance; Becton Dickinson; Lab901

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Correlogic Systems this week said that it has fulfilled European Union regulatory requirements to CE Mark its OvaCheck test for epithelial ovarian cancer. The test is a multiplex assay that measures the relative ratios of eight proteins. The Germantwon, Md.-based firm said that it is currently in discussions with potential partners for distribution of OvaCheck in Europe.

NanoString Technologies has launched an early-access program for its nCounter Custom Copy Number Variation Assays for highly multiplexed, direct-digital detection, and counting of CNVs in a single reaction. The firm expects to commercially launch the CNV assays later this year.

Covance this week said that it has opened a new, 20,000-square-foot biorepository to hold its plasma, serum, whole-blood, DNA, PBMC, and tissue samples. The new facility is adjacent to Covance's Biomarker Center of Excellence in Greenfield, Ind.

Becton Dickinson has signed agreements this week to sell certain assets of its BD Medical segment, including its ophthalmic systems unit and the surgical blades, critical care, and extended dwell catheter product platforms of its medical surgical systems unit. Private equity firm RoundTable Healthcare Partners and two of its portfolio companies, Argon Medical Devices and Aspen Surgical Products, are buying the BD assets for an undisclosed sum. BD said the businesses would bring in estimated revenues of $200 million for fiscal-year 2010.

Lab901 has received IS O9001:2008 accreditation for manufacturing quality covering its ScreenTape System for automated gel electrophoresis.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.